BC
VERA icon

Bayforest Capital’s Vera Therapeutics VERA Stock Holding History

Bayforest Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$63.2K Sell
1,958
-896
-31% -$31.3K 0.09% 418
2026
Q2 		$122K Buy
2,854
+2,439
+588% +$90.9K 0.11% 359
2026
Q1 		$16.7K Buy
+415
New +$17.9K 0.02% 752

Other funds holding VERA

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
JHC
Jones Hill Capital New York $589M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bayforest Capital's VERA Position: Q3 2026 in Review

Bayforest Capital reduced its Vera Therapeutics (VERA) stake by 31% in Q3 2026, selling an estimated $31.3K and leaving 1,958 shares worth $63.2K. The position accounts for 0.09% of the portfolio, ranked #418.

Bayforest Capital first reported a position in VERA in Q1 2026 and has held it in 3 quarters since. The position peaked at $122K in Q2 2026. 136 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Bayforest Capital held 1,958 shares of Vera Therapeutics worth $63.2K as of Q3 2026.
  • Bayforest Capital sold 896 Vera Therapeutics shares in Q3 2026, an estimated $31.3K.
  • Vera Therapeutics made up 0.09% of Bayforest Capital's portfolio in Q3 2026, its #418 holding.
  • Bayforest Capital first reported a position in Vera Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Bayforest Capital's Vera Therapeutics position peaked at $122K in Q2 2026.
  • 136 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.